State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT05223816 Phase 2
Recruiting
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Eff...
Condition
Hepatocellular Carcinoma
Enrollment
97 pts
Location
United States
Sponsor
Virogin Biotech Canada Ltd
NCT05038150 Phase 1, Phase 2
Recruiting
Study of SGN1 in Patients With Advanced Solid Tumor
Condition
Advanced Solid Tumor
Enrollment
70 pts
Location
United States, China
Sponsor
Guangzhou Sinogen Pharmaceutic
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT03168659 N/A
Recruiting
CardioFocus HeartLight Post-Approval Study
Condition
Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
CardioFocus
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT05412927 N/A
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Condition
Acute Coronary Syndrome
Enrollment
500 pts
Location
United States
Sponsor
Angel Medical Systems
NCT05033990 N/A
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
Condition
COPD, Early-Onset
Enrollment
1,000 pts
Location
United States
Sponsor
University of Massachusetts, W
NCT05294991 N/A
Recruiting
Wellness App for Sleep Disturbance in Hematological Cancer Patients
Condition
Cancer
Enrollment
276 pts
Location
United States
Sponsor
The University of Texas Health
NCT07007559 Phase 1, Phase 2
Recruiting
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Adv...
Condition
Breast Cancer, Metastatic
Enrollment
80 pts
Location
United States
Sponsor
ALX Oncology Inc.
NCT06123988 N/A
Recruiting
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reporte...
Condition
HER2-positive Breast Cancer
Enrollment
260 pts
Location
United States
Sponsor
University of Miami
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory...
Condition
Neuroblastoma
Enrollment
104 pts
Location
United States, Canada
Sponsor
Milton S. Hershey Medical Cent
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05329103 Phase 1
Recruiting
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
65 pts
Location
United States
Sponsor
Peel Therapeutics Inc
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT07215312 Phase 2
Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wit...
Condition
Diabetes Mellitus, Type 2
Enrollment
100 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT06961370 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodyna...
Condition
Geographic Atrophy
Enrollment
132 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States
Sponsor
Axon Therapies, Inc.
NCT06897475 Phase 2
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes ...
Condition
Type 2 Diabetes
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Eli Lilly and Company
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology